Clomiphene Citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial

[1] Gianaroli L(2012)Consensus on women’s health aspects of polycystic ovary syndrome (PCOS) Hum Reprod 27 14-24

[2] Racowsky C(2012)Best practices of ASRM and ESHRE: a journey through reproductive medicine Hum Reprod 27 3365-3379

[3] Geraedts J(2003)Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility Semin Reprod Med 1 39-47

[4] Cedars M(2009)Management strategies for ovulation induction in women with PCOS and known clomiphene citrate resistance Curr Opin Obstet Gynecol 21 465-473

[5] Makrigiannakis A(1996)Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women J Clin Endocrinol Metab 81 3821-3824

[6] Roger L(2000)Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol J Assist Reprod Genet 17 561-565

[7] Eijkemans J(2012)Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study Hum Reprod 27 468-473

[8] Habbema D(1993)Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone Hum Reprod 8 56-59

[9] Fauser C(2006)Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation Hum Reprod 22 2838-2844

[10] Palomba S(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-47

[1] Gianaroli L(2012)Consensus on women’s health aspects of polycystic ovary syndrome (PCOS) Hum Reprod 27 14-24

[2] Racowsky C(2012)Best practices of ASRM and ESHRE: a journey through reproductive medicine Hum Reprod 27 3365-3379

[3] Geraedts J(2003)Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility Semin Reprod Med 1 39-47

[4] Cedars M(2009)Management strategies for ovulation induction in women with PCOS and known clomiphene citrate resistance Curr Opin Obstet Gynecol 21 465-473

[5] Makrigiannakis A(1996)Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women J Clin Endocrinol Metab 81 3821-3824

[6] Roger L(2000)Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol J Assist Reprod Genet 17 561-565

[7] Eijkemans J(2012)Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study Hum Reprod 27 468-473

[8] Habbema D(1993)Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone Hum Reprod 8 56-59

[9] Fauser C(2006)Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation Hum Reprod 22 2838-2844

[10] Palomba S(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-47